A Win For Ra Medical Systems, Inc.

Ra Medical Systems, Inc. (RMED:NYSE) jumped higher at $3.92, representing a gain of 18.1%. On Tue, May 11, 2021, RMED:NYSE touched a New 2-Week Low of $3.32. The stock got featured on our News Catalysts scanner on Tue, May 11, 2021 at 06:06 PM in the 'EARNINGS' category. From Tue, Apr 27, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, May 05, 2021 at $4.94 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Ra Medical Systems, Inc. (RMED:NYSE)
Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. Generating, its revenue from the Dermatology segment.
Top 10 Gainers:
- REVH (REVH:NASDAQ), 2074.47%
- Curis, Inc. (CRIS:NASDAQ), 65.51%
- LHDX (LHDX:NASDAQ), 44.2%
- Autolus Therapeutics plc (AUTL:NASDAQ), 35.47%
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 31.01%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 27.6%
- ShotSpotter, Inc. (SSTI:NASDAQ), 25.39%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 23.97%
- LRMR (LRMR:NASDAQ), 23.68%
- Ra Medical Systems, Inc. (RMED:NYSE), 18.07%